[Bleedings during vitamin K antagonist therapy associated with ciclosporin and rifampicin]

MeSH terms

• Aged
• Anticoagulants / adverse effects*
• Anticoagulants / therapeutic use
• Antitubercular Agents / administration & dosage
• Antitubercular Agents / adverse effects*
• Comorbidity
• Cyclosporine / administration & dosage
• Cyclosporine / adverse effects*
• Drug Substitution
• Drug Therapy, Combination
• Female
• Hemorrhage / chemically induced*
• Hemorrhage / drug therapy
• Heparin / adverse effects*
• Heparin / therapeutic use
• Humans
• Immunosuppressive Agents / administration & dosage
• Immunosuppressive Agents / adverse effects*
• Kidney Transplantation
• Lung Diseases, Interstitial / chemically induced
• Pericarditis / chemically induced
• Phenindione / adverse effects
• Phenindione / analogs & derivatives*
• Phenindione / pharmacology
• Phenindione / therapeutic use
• Polypharmacy
• Postoperative Complications / chemically induced*
• Postoperative Complications / drug therapy
• Rifampin / adverse effects*
• Sirolimus / adverse effects
• Venous Thrombosis / drug therapy
• Vitamin K / antagonists & inhibitors*
• Vitamin K / therapeutic use